首页|某三甲医院尿路感染患者病原菌分布及药敏分析

某三甲医院尿路感染患者病原菌分布及药敏分析

扫码查看
目的 了解自贡市第三人民医院尿路感染患者病原菌分布及药敏耐药性特点,为临床医师合理选用抗菌素及控制院内感染、降低细菌耐药性提供帮助.方法 收集 2019 年 1月—2020 年 12 月自贡市第三人民医院尿路感染就诊患者尿液标本 3 802 份,采用MicroScan Walk/Away-40(美国SIEMENS公司)全自动微生物鉴定和药敏系统进行细菌鉴定和药敏试验.结果 539 株分离菌中革兰阴性菌 411 株,占比 76.25%;革兰阳性菌 128 株,占比 23.75%;其中前 5位的菌株 416 株,依次为大肠埃希菌 294 株(54.55%)、粪肠球菌 46 株(8.53%)、肺炎克雷伯菌 38 株(7.05%)、屎肠球菌 23 株(4.27%)、奇异变形杆菌 15 株(2.78%).前5 位 3 种革兰阴性菌中,大肠埃希菌对复方新诺明、环丙沙星、头孢唑啉及左旋氧氟沙星耐药率均>50.00%,对头孢噻肟、头孢曲松、氨曲南和头孢吡肟耐药率均>40.00%,庆大霉素为 35.71%,其余均在 30.00%以内;肺炎克雷伯菌对复方新诺明耐药性最高为 52.63%,其次是头孢唑林为 42.11%、头孢噻肟为 36.84%、环丙沙星和头孢曲松均为 31.58%,其余均在 30.00%以内;奇异变形杆菌,对复方新诺明耐药率最高为 60.00%,其次环丙沙星为 53.33%、妥布霉素为 46.67%,头孢唑啉、庆大霉素和氨曲南均为33.33%,其余均在 30.00%以内.前 5 位 2 种革兰阳性菌中,粪肠球菌,对四环素耐药性最高为 86.96%,其次红霉素为 76.09%、利福平为 54.35%,环丙沙星为 32.61%、左旋氧氟沙星和莫西沙星均为30.43%,其余均在30.00%以内;屎肠球菌,对红霉素、环丙沙星和左旋氧氟沙星耐药率均为100%,其次青霉素G为 95.65%、莫西沙星为 91.30%、利福平和阿莫西林/克拉维酸均为 82.61%、四环素为 65.22%,对大多数抗菌药物耐药率均较高,其中对万古霉素耐药率最低为 4.35%,其次为利奈唑胺为 5.26%、呋喃妥因为 8.70%.结论 临床医师在诊疗过程中,应加强与实验室合作,重视尿路感染的病原学检查,在选用抗菌药物治疗时应结合实验室病原学报告和药敏试验结果,合理使用抗菌药物,同时遏制细菌耐药性.
Distribution and Drug Sensitivity of Pathogens in Urinary Tract Infection Patients in a 3A Hospital
Objective To investigate the distribution,drug sensitivity and drug resistance of pathogens in patients with urinary tract infection(UTI)in Zigong Third People's Hospital,so as to help clinicians to select antibiotics reasonably,control nosocomial infection and reduce bacterial drug resistance.Methods A total of 3 802 urine samples were collected from patients with urinary tract infection in Zigong Third People's Hospital from January 2019 to December 2020,and the bacteria identification and drug sensitivity test were carried out by MicroScanWalk/Away-40(SIEMENS,USA)automatic microbial identification and drug sensitivity system.Results Among the 539 isolates,411 were Gram-negative bacteria,accounting for 76.25%.Gram-positive bacteria 128 strains,accounting for 23.75%.The top five strains were Escherichia coli 294 strains(54.55%),Enterococcus faecalis 46 strains(8.53%),Klebsiella pneumoniae 38(7.05%),Enterococcus faecium 23 strains(4.27%)and Proteus mirabilis 15 strains(2.78%).Among the first five Gram-negative bacteria,the resistance rates of Escherichia coli to trimethoprim/sulfamethoxazole,ciprofloxacin,cefazolin and levofloxacin were more than 50.00%,to cefotaxime,ceftriaxone,aztreonam and cefepime were more than 40%,to gentamicin was 35.71%,and the others were less than 30%.Klebsiella pneumoniae had the highest resistance rate to SMZ-TMP(52.63%),followed by cefazolin(42.11%),cefotaxime(36.84%),ciprofloxacin(31.58%)and ceftriaxone(31.58%).Proteus mirabilis were excluded from the natural resistance of antimicrobial agents,the highest resistance rate of SMZ-TMP was 60.00%,followed by ciprofloxacin 53.33%,tobramycin 46.67%,cefazolin,gentamicin and aztreonam were 33.33%,the rest were less than 30.00%.Among the first five Gram-positive bacteria,the resistance of Enterococcus faecalis to tetracycline was 86.96%,erythromycin 76.09%,rifampicin 54.35%,ciprofloxacin 32.61%,levofloxacin and moxifloxacin 30.43%,and the others were all within 30%.The resistant rates of erythromycin,ciprofloxacin and levofloxacin were all 100%,penicillin G was 95.65%,moxifloxacin was 91.30%,rifampicin and amoxicillin/clavulanic acid were 82.61%and tetracycline was 65.22%.The resistance rate to vancomycin was the lowest(4.35%),followed by linezolid(5.26%)and nitrofurantoin(8.70%).Conclusion In the process of diagnosis and treatment,clinicians should strengthen the cooperation with the laboratory,pay attention to the etiology examination of urinary tract infection,combine the laboratory etiology report and drug sensitivity test results in the selection of antimicrobial therapy,use antimicrobial drugs rationally,and curb bacterial resistance.

urinary tract infectionpathogenic bacteriadistribution of pathogenic bacteriadrug sensitivitydrug resistanceantimicrobial agents

陈月华、颜小平、江利沙、郝玉清

展开 >

自贡市妇幼保健院检验科,四川 自贡 643010

自贡市第三人民医院输血科,四川 自贡 643021

自贡市第三人民医院检验科,四川 自贡 643021

尿路感染 病原菌 病原菌分布 药敏 耐药性 抗菌药物

2024

中国卫生标准管理
《中国卫生标准管理》杂志社

中国卫生标准管理

影响因子:1.374
ISSN:1674-9316
年,卷(期):2024.15(1)
  • 1
  • 14